Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07173322 · ClinicalTrials.gov registry record

The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey

A clinical trial of Cancer, sponsored by Blood Cancer United.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT07173322 is a study of Cancer that is actively recruiting participants, run by Blood Cancer United. The registered enrollment target is 200 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07173322, a study of Cancer, is actively recruiting participants, sponsored by Blood Cancer United.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

As there is limited knowledge regarding the impact of CAR-T Cell therapy on fertility, LLS has designed a Patient Survey to learn more about the impact on fertility in patients who have received/are receiving CAR-T Cell treatment. The insights gained from this survey will inform future treatment protocols and fertility preservation strategies.

Conditions Studied

Study Locations (1)

New York

  • Internet - Rye

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-02-09
Est. Completion 2026-02-09

Sponsor

Blood Cancer United

4 total trials

What the Registry Record Tells You About NCT07173322

The ClinicalTrials.gov registry entry for NCT07173322 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Blood Cancer United, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT07173322 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07173322 about?

NCT07173322 is a clinical study titled "The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey". As there is limited knowledge regarding the impact of CAR-T Cell therapy on fertility, LLS has designed a Patient Survey to learn more about the impact on fertility in patients who have received/are receiving CAR-T Cell treatment. The insights gained from this survey will inform future treatment pro...

What is the current status of trial NCT07173322?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-02-09. Estimated completion is 2026-02-09.

What conditions does trial NCT07173322 study?

This clinical trial studies the following conditions: Cancer.

Who is sponsoring clinical trial NCT07173322?

This trial is sponsored by Blood Cancer United, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07173322 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.